Pictured: Gil Redelman-Sidi

Gil Redelman-Sidi, MD

Infectious Diseases Specialist

Areas of Expertise

Conditions I Treat

  • Infectious diseases
  • Infections in the immunocompromised
View all expertise
Dr. Redelman-Sidi's Office Information
Languages: English & Hebrew
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
Back to top

Get to Know Me

I am an internist and infectious disease specialist with a special interest in the care of patients with infections related to cancer or its treatment. I am particularly interested in treating mycobacterial infections among immunocompromised patients, including infections with nontuberculous mycobacteria.

Read more

The focus of my laboratory research is the use of Bacillus Calmette-Guerin (BCG), a bacterium normally used as a vaccine against tuberculosis, as an immunotherapy for bladder cancer. The aim of my research is to understand the mechanism of action of BCG, with the long-term goal of translating this understanding into improved care for patients with early-stage bladder cancer.

In the past several years, the field of cancer immunotherapy has expanded far beyond BCG therapy for bladder cancer. These exciting new therapies are associated with robust response rates, but the full extent of side effects associated with these agents is yet unknown. My fascination with BCG immunotherapy of bladder cancer has also led to an interest in these novel methods of immunotherapy, and I have embarked on a study of infections among patients receiving various forms of cancer immunotherapy. 

What I Do at MSK

I'm an infectious (in-FEK-shuhs) disease specialist. This is a doctor with special training in diseases caused by microorganisms (bacteria, fungi, parasites, and viruses).

  • Assistant Attending Physician
Areas of Expertise

Conditions I Treat

  • Infectious diseases
  • Infections in the immunocompromised
Education & Honors

Education

  • MD, Sackler School of Medicine (Israel)

Residencies

  • Jacobi Medical Center (New York)

Fellowships

  • Memorial Sloan Kettering Cancer Center

Board Certifications

  • Internal Medicine
  • Infectious Disease

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 212-639-7810— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by logging in to MSK MyChart or calling your Care Team. If you are not enrolled in MSK MyChart, ask your Care Team to send you an invitation. You can also go to MSK MyChart and select “Sign up now.”

Contact and Location

Dr. Redelman-Sidi sees patients at one location.

Office Phone
Location
New York, NY
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
530 East 74th Street New York NY 10021
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Infectious Diseases and Allergy Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

View Dr. Redelman-Sidi's Research

Visit PubMed for a full listing of Gil Redelman-Sidi’s journal articles.

Books and Book Chapters
“Patients with Cancer or Hematopoietic Stem Cell Transplant: Infection with 2009H1N1 Influenza.” Redelman-Sidi G. Chapter 38 in Stem Cells and Cancer Stem Cells: Therapeutic Applications in Disease and Injury, Volume 2. MA Hayat, ed. Springer 2012.

“Rhodotorual Species.” Gil Redelman-Sidi, Susan K. Seo, Arthur E. Brown. In Antimicrobial Therapy and Vaccines; Volume 1: Microbes (www.antimicrobe.org). Yu VL, et al, editors. ESun Technologies, Pittsburgh, PA, 2007.

“Relapsing Fever,” Gil Sidi, Eli Schwartz. Chapter 19 in Tropical Diseases in Travelers, E. Schwartz. Wiley-Blackwell, July 2009.

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Gil Redelman-Sidi discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures

Related topics: